Dendritic Cell Therapyterapija

Dendritic Cell Therapy is one of the groundbreaking clinical cancer treatments that are highlighted among the medical community.

Let us explain how and why we offer DCV in our clinic.

Dendritic Cell Therapy boosts the numbers by taking some immature Dendritic Cells from the patient’s own blood and cultivating, processing, and activating them in the laboratory. It is a complex and highly specialized process that only a few laboratories can perform. In the end, the patient receives certification on quality to get the very best quality of cells.

Dendritic Cell therapy is one of the immunotherapy treatments, which change the landscape of what we think about managing advanced disease.

How does the DCT affect cancer cells?

• The impact of DCV on tumor cells is not direct but based on the reprogramming of the antitumor immune response, which is a complicated multistage process.
  
  
• Dendritic cells are a type of immune cells that play a very important role in starting the immune response – circulating in the blood as monocytes they are the first to come into contact with a presentable antigen, becoming activated into mature dendritic cells and then migrating to the lymph nodes, where they interact with other elements of the immune system.
  
  
• Monocytes are isolated from the patient’s blood, then a mixture of tumor-derived peptide antigens is added to the cell culture in the lab. After this maturation, dendritic cells are now presenting specific tumor antigens on their surface and, when reintroduced back into patient’s blood, they trigger other types of immune cells – the T and B cells – to destroy the cancer cells specifically.